Experimental and Theoretical Insights on Chemopreventive Effect of the Liposomal Thymoquinone Against Benzo[a]pyrene-Induced Lung Cancer in Swiss Albino Mice
Authors:
- Arif KhanAKArif Khan
- Mohammed A AlsahliMAMohammed A Alsahli
- Mohammad A AljasirMAMohammad A Aljasir
- Mugahid A MobarkMMMugahid A Mobark
- Faizul AzamFaizul Azam
- Khaled S AllemailemKhaled S Allemailem
- Faris AlrumaihiFAFaris Alrumaihi
- Fahad A AlhumaydhiFahad A Alhumaydhi
- Ahmad A AlmatroudiAAAhmad A Almatroudi
- Masood A KhanMasood A Khan
Open Access
- 1 April 2022
- journal article
- research article
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 15, 2263-2280
Abstract
Purpose: Thymoquinone (TQ), a phytoconstituent of Nigella sativa seeds, has been studied extensively in various cancer models. However, TQ’s limited water solubility restricts its therapeutic applicability. Our work aims to prepare the novel formulation of TQ and assess its chemopreventive potential in chemically induced lung cancer animal model. Methods: The polyethylene glycol coated DOPE/CHEMS incorporating TQ-loaded pH-sensitive liposomes (TQPSL) were prepared and characterized. Mice were exposed to benzo[a]pyrene (BaP) thrice a week for 4 weeks to induce lung cancer. TQPSL was administered three times a week for 21 weeks, starting 2 weeks before the first dose of BaP. Results: The prepared TQPSL revealed 85% entrapment efficiency with 128 nm size and − 19.5 mv ζ-potential showing high stability of the formulation. The pretreatment of TQPSL showed the recovery in BaP-modulated relative organ weight of lungs, cancer marker enzymes, and antioxidant enzymes in the serum. The histopathological analysis of the tissues showed that TQPSL protected the malignancy in the lungs. The flow cytometry data revealed the induction of apoptosis and decreased intracellular ROS by TQPSL. Molecular docking was performed to predict the TQ’s affinity for eight possible anticancer drug targets linked to lung cancer etiology. The data assisted to identify the serine/threonine-protein kinase BRAF as the most suitable target of TQ with binding energy − 6.8 kcal/mol. Conclusion: The current findings demonstrated the potential of TQPSL and its possible therapeutic targets of lung cancer. To our knowledge, this is the first research to outline the development of TQ formulation against lung cancer considering its low solubility as well as pulmonary delivery challenges.Keywords
This publication has 84 references indexed in Scilit:
- Diagnostic Utility of Adenosine Deaminase in Serum and Bronchoalveolar Lavage Fluid for Screening Lung Cancer in Western IranJournal of Medical Biochemistry, 2013
- Distribution of Primary and Specialized Metabolites in Nigella sativa Seeds, a Spice with Vast Traditional and Historical UsesMolecules, 2012
- Oxidative stress, inflammation, and cancer: How are they linked?Free Radical Biology and Medicine, 2010
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJournal of Computational Chemistry, 2009
- Thymoquinone: A promising anti-cancer drug from natural sourcesThe International Journal of Biochemistry & Cell Biology, 2006
- The Effect of Different Lipid Components on the In Vitro Stability and Release Kinetics of Liposome FormulationsDrug Delivery, 2004
- Induction of Apoptosis by Cancer ChemotherapyExperimental Cell Research, 2000
- Sterically stabilized liposomesBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1992
- The reaction of (±)‐7α, 8β‐dihydroxy‐9β, 10β‐epoxy‐7,8,9,10‐tetrahydrobenzo(a)pyrene with dnaInternational Journal of Cancer, 1976
- Oral administration of insulin by encapsulation within liposomesFEBS Letters, 1976